SCHEMBL30740779

SCHEMBL30740779

Clc1ccc(OCc2ncccc2CBr)c(Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR4 O95977 3/20 0.53
MRGPRX4 Q96LA9 11/20 0.48
NPC1 O15118 5/20 0.43
RAB9A P51151 5/20 0.43
HPGD P15428 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
TSHR P16473 2/20 0.43
TP53 P04637 2/20 0.43
LMNA P02545 1/20 0.43
NFKB1 P19838 1/20 0.43
CASP3 P42574 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
STAT3 P40763 1/20 0.42
STAT1 P42224 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MITF O75030 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30745406 0.83 S1PR4 (0.59) S1PR4MRGPRX4NPC1RAB9AHPGD
SCHEMBL18783678 0.71 MAPT (0.57) MRGPRX4NPC1RAB9AHPGDSMN1; SMN2
SCHEMBL14774697 0.70 MAPK14 (0.46) PKM
SCHEMBL8618574 0.70 MRGPRX4 (0.62) MRGPRX4NPC1RAB9AHPGDSMN1; SMN2
SCHEMBL6958628 0.70 SLC6A2 (0.66) HPGDLMNA
SCHEMBL11840387 0.69 TDP1 (0.56) S1PR4MRGPRX4HPGDSMN1; SMN2TSHR
SCHEMBL27298983 0.69 PDK2 (0.40) S1PR4MRGPRX4NPC1RAB9AHPGD
SCHEMBL30745344 0.69 MRGPRX4 (0.45) S1PR4MRGPRX4NPC1RAB9AHPGD
SCHEMBL5466462 0.69 ALDH1A1 (0.40) NPC1RAB9ASMN1; SMN2TSHRTP53
SCHEMBL11711706 0.69 MRGPRX4 (0.65) MRGPRX4NPC1RAB9AHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117043154-A GPCR receptor agonists, pharmaceutical compositions comprising same, and methods of use thereof 卡莫特医疗有限公司 2023-11-10 CN disclosed